Hasnain Faheem
Insider CIK 1352620 · AMBI Director · VTL Director · SOMX Director · TOCA Director · NONE Director · RCPT President, CEO, Director · MRTX Director · GOSS President & CEO, Director · NUVB Director · ASPE Executive Chair, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 7,120 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 14,316 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 14,913 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 7,120 | — | — | 7,120 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 14,316 | — | — | 14,316 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 14,913 | — | — | 14,913 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 166 | $1000.00 | $166.0K | 166 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 5,800,051 | — | $0 | 5,800,051 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 5,800,051 | — | $0 | 5,800,051 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-08-24 | 2026-08-26 | 166 | $1000.00 | $166.0K | 166 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 1,312,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 1,540,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 1,680,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 43,500 | — | $0 | 43,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 47,000 | — | $0 | 47,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 325,000 | — | $0 | 325,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 650,000 | — | $0 | 650,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 544,500 | — | $0 | 544,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 544,500 | — | $0 | 544,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 437,500 | — | $0 | 437,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 1,312,500 | — | $0 | 1,312,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 1,540,000 | — | $0 | 1,540,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 1,680,000 | — | $0 | 1,680,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 43,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 47,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 325,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 650,000 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 544,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 437,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-20 | 544,500 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 1,680,000 | — | $0 | 1,680,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2026-01-02 | 2026-01-05 | 280,000 | — | $0 | 837,793 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2025-12-09 | 2025-12-10 | 10,000 | $10.98 | $109.8K | 23,983 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2025-12-09 | 2025-12-10 | 10,000 | $3.12 | $31.2K | 33,983 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2025-10-01 | 2025-10-02 | 437,500 | — | $0 | 557,793 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 28,500 | — | $0 | 28,500 | SEC↗ |
| KURA Kura Oncology, Inc. | S Sale | 2025-03-21 | 2025-03-24 | 22,682 | $8.00 | $181.5K | 23,983 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2025-03-21 | 2025-03-24 | 22,682 | $6.32 | $143.4K | 46,665 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2025-03-04 | 2025-03-06 | 1,540,000 | — | $0 | 1,540,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2024-06-21 | 2024-06-24 | 372,000 | $0.67 | $249.2K | 5,408,073 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2024-03-27 | 2024-03-28 | 23,172 | $1.16 | $26.9K | 120,293 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 10,716 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 35,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 8,717 | — | $0 | 16,035 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 9,702 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,333 | — | $0 | 9,702 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 1,312,500 | — | $0 | 1,312,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 9,702 | $58.75 | $570.0K | 24,752 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 437,500 | — | $0 | 437,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-14 | 10,791 | $27.80 | $300.0K | 10,791 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 135,044 | $0.13 | $17.6K | 135,044 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2023-07-24 | 2023-07-26 | 540,176 | $1.82 | $983.1K | 5,036,073 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-05-05 | 2023-05-09 | 750,000 | — | $0 | 750,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-03-22 | 2023-03-22 | 440,500 | $1.14 | $502.2K | 4,495,897 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-03-21 | 2023-03-22 | 269,389 | $1.20 | $323.3K | 4,055,397 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-03-20 | 2023-03-22 | 544,500 | — | $0 | 544,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2023-03-20 | 2023-03-22 | 168,683 | $1.03 | $173.7K | 3,786,008 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 10,716 | — | $0 | 10,716 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 6,333 | — | $0 | 15,050 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-12-07 | 2022-12-09 | 544,500 | — | $0 | 544,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2022-07-15 | 2022-07-15 | 138,696 | $7.21 | $1000.0K | 3,617,325 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2022-06-21 | 2022-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | S Sale | 2022-03-23 | 2022-03-24 | 19,035 | $8.92 | $169.8K | 143,465 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 5,243 | — | $0 | 5,243 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 3,619 | — | $0 | 8,717 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-01-06 | 2022-01-10 | 650,000 | — | $0 | 650,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 325,000 | — | $0 | 325,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2021-02-25 | 2021-03-01 | 162,500 | — | $0 | 162,500 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise deriv | 2021-02-10 | 2021-02-26 | 25,000 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-26 | 30,000 | $10.00 | $300.0K | 55,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | M Exercise | 2021-02-10 | 2021-02-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 3,064 | — | $0 | 3,064 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 2,098 | — | $0 | 5,098 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2020-10-14 | 2020-10-14 | 96,520 | $10.36 | $999.9K | 3,478,629 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 23,000 | — | $0 | 23,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 47,000 | — | $0 | 47,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 3,000 | — | $0 | 3,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-09-27 | 2019-09-27 | 10,000 | $16.80 | $168.0K | 3,382,109 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 13,000 | — | $0 | 13,000 | SEC↗ |
| TOCA Tocagen Inc | P Buy | 2019-05-30 | 2019-06-03 | 38,860 | $4.59 | $178.4K | 241,717 | SEC↗ |
| TOCA Tocagen Inc | P Buy | 2019-05-30 | 2019-06-03 | 250 | $5.15 | $1.3K | 245,857 | SEC↗ |
| TOCA Tocagen Inc | P Buy | 2019-05-30 | 2019-06-03 | 3,890 | $5.30 | $20.6K | 245,607 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 43,500 | — | $0 | 43,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-02-15 | 2019-02-20 | 47,000 | — | $0 | 47,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 77,719 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 185,984 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 58,599 | — | $0 | 3,372,109 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-13 | 2018-09-17 | 59,200 | $0.44 | $26.0K | 122,743 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-13 | 2018-09-17 | 118,243 | $0.44 | $52.0K | 4,500 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 13,000 | — | $0 | 13,000 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2018-05-23 | 2018-05-25 | 41,353 | — | $0 | 41,353 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-09-14 | 2017-09-15 | 59,200 | $4.19 | $248.0K | 181,943 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2017-09-05 | 2017-09-06 | 15,222 | — | $0 | 15,222 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-06-09 | 2017-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2017-05-23 | 2017-05-25 | 45,022 | — | $0 | 45,022 | SEC↗ |
| TOCA Tocagen Inc | J Other | 2017-04-19 | 2017-04-21 | 102,857 | $10.00 | $1.03M | 102,857 | SEC↗ |
| TOCA Tocagen Inc | P Buy | 2017-04-19 | 2017-04-21 | 100,000 | $10.00 | $1.00M | 202,857 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2017-04-12 | 2017-04-12 | 10,869 | — | $0 | 10,869 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2016-08-12 | 2016-08-15 | 118,243 | $5.92 | $700.0K | 122,743 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2016-08-11 | 2016-08-15 | 58,574 | — | $0 | 58,574 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-05-12 | 2016-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 133,333 | $223.90 | $29.85M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 106,107 | $190.49 | $20.21M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 143,500 | $213.23 | $30.60M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 32,500 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 384,409 | — | $0 | 32,500 | SEC↗ |
| NONE Kura Oncology, Inc. | A Award deriv | 2015-04-23 | 2015-04-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-04-01 | 2015-04-03 | 32,500 | — | $0 | 416,909 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-11-11 | 2014-11-12 | 63,205 | $108.99 | $6.89M | 387,409 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 8,000 | $8.67 | $69.4K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 775 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 20,000 | $15.00 | $300.0K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 62 | — | $0 | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 7,085 | $8.34 | $59.1K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 144,259 | $9.00 | $1.30M | 0 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-11-10 | 2014-11-12 | 136,795 | $109.69 | $15.01M | 450,614 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-07-15 | 2014-07-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-05-15 | 2014-05-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-04-03 | 2014-04-07 | 106,107 | — | $0 | 106,107 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 143,500 | — | $0 | 143,500 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2013-05-21 | 2013-05-21 | 7,085 | — | $0 | 7,085 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 357,142 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 47,618 | $5.25 | $250.0K | 584,409 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 27,974 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 7,230 | — | $0 | 24,454 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 32,586 | — | $0 | 137,798 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 45,789 | — | $0 | 105,212 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award deriv | 2012-05-31 | 2012-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-04-02 | 2012-04-04 | 59,423 | — | $0 | 59,423 | SEC↗ |